Reshmi Parameswaran

782 citations

27 papers · 525 indexed · h-index 13

Impact in

Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Galectins and Cancer Biology
- Immunotherapy and Immune Responses
Oncology
- CAR-T cell therapy research

Papers in

Immunology 12
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 6
Genetics 5
- Chronic Lymphocytic Leukemia Research 3

Co-authors: Parameswaran Ramakrishnan Abhishek Asthana Keman Zhang John Groffen Nora Heisterkamp Rose Beck Dov Zipori Zhiqiang Xia
Journals: Molecular Cancer Therapeutics (2 papers)Blood (2 papers)Nature Communications (2 papers)Frontiers in Immunology (2 papers)Cancer Research (2 papers)
Partner nations: United States Israel Switzerland

In The Last Decade

Reshmi Parameswaran

25 papers receiving 520 citations

Peers

Countries citing papers authored by Reshmi Parameswaran

Since Specialization

Citations

This map shows the geographic impact of Reshmi Parameswaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reshmi Parameswaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reshmi Parameswaran more than expected).

Fields of papers citing papers by Reshmi Parameswaran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reshmi Parameswaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reshmi Parameswaran. The network helps show where Reshmi Parameswaran may publish in the future.

Co-authors

The 25 scholars most cited alongside Reshmi Parameswaran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Reshmi Parameswaran Line = papers co-authored together Reshmi Parameswaran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	EFFICIENT COST-EFFECTIVE MANUFACTURE OF A NON-VIRAL TRANSPOSON BASED NOVEL BAFF-CART FOR TREATMENT OF B-CELL CANCERS Cytotherapy ·Andrew D. Lawrence, Titilola Oguntona, Junwei Xu, Paolo F. Caimi, Reshmi Parameswaran, Jane Reese	2025	0
2	CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapy Journal of Autoimmunity ·Kaitlin Walsh Carson, Fuli He, Julia Rosenberger, Daniel Feinberg, Beau R. Webber, Branden S. Moriarity, Reshmi Parameswaran	2025	9
3	p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction Cancer Research Communications ·Melville Brockett Fenton, Agustín Amaro Frontán Goldoni, Daniel Feinberg, Alex Y. Huang, Reshmi Parameswaran	2023	2
4	A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers Nature Communications ·Melville Brockett Fenton, Nand Kishor Roy, Keman Zhang, 仲宗根良治, Abhishek Asthana, Sinara Adriana Strassburg, Samantha K. Dunmire, Bryan J. Jones, Walker S. Lahr, Beau R. Webber, Branden S. Moriarity, Paolo F. Caimi, Reshmi Parameswaran	2022	59
5	Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells Frontiers in Immunology ·Daniel Feinberg, Parameswaran Ramakrishnan, Melville Brockett Fenton, Abhishek Asthana, Reshmi Parameswaran	2022	14
6	NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells Frontiers in Immunology ·Zhitong Chai, Melville Brockett Fenton, Nand Kishor Roy, 潘红霞, Keman Zhang, Parameswaran Ramakrishnan, Reshmi Parameswaran	2021	12
7	Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia Cancer Immunology Research ·Zhitong Chai, Hermann Gram, Rose Beck, Abhishek Asthana, Keman Zhang, Melville Brockett Fenton, A P Greibe, Reshmi Parameswaran	2019	10
8	Wheat Germ Agglutinin as a Potential Therapeutic Agent for Leukemia Frontiers in Oncology ·Yoshinaga Sayaka, Keman Zhang, Abhishek Asthana, Melville Brockett Fenton, Zhitong Chai, Reshmi Parameswaran	2019	46
9	Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death Molecular Cancer Therapeutics ·Abhishek Asthana, Parameswaran Ramakrishnan, Zhitong Chai, Keman Zhang, Reshmi Parameswaran	2018	48
10	Repression of GSK3 restores NK cell cytotoxicity in AML patients Nature Communications ·Reshmi Parameswaran, Parameswaran Ramakrishnan, Stephen Moreton, Zhiqiang Xia, Yongchun Hou, Dean A. Lee, Kalpana Gupta, Marcos de Lima, Rose Beck, David N. Wald	2016	95
11	Effector-Mediated Eradication of Precursor B Acute Lymphoblastic Leukemia with a Novel Fc-Engineered Monoclonal Antibody Targeting the BAFF-R Molecular Cancer Therapeutics ·Reshmi Parameswaran, Olaf Sporns, Fei Fei, Hisham Abdel‐Azim, Anna Arutyunyan, L. Kamenoff, Margaret E. McLaughlin, Hermann Gram, Heather Huet, John Groffen, Nora Heisterkamp	2014	32
12	O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia The Journal of Experimental Medicine ·Reshmi Parameswaran, Olaf Sporns, Anna Arutyunyan, Hisham Abdel‐Azim, Christian Hurtz, Kam Lau, Markus Müschen, Robert K. Yu, Mark von Itzstein, Nora Heisterkamp, John Groffen	2013	34
13	A Functional Receptor for B-Cell–Activating Factor Is Expressed on Human Acute Lymphoblastic Leukemias Cancer Research ·Reshmi Parameswaran, Markus Müschen, Yong‐Mi Kim, John Groffen, Nora Heisterkamp	2010	46
14	B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus Clinical Immunology ·Reshmi Parameswaran, Carly Homan, Amir Sharabi, Heidy Zinger, Edna Mozes	2009	23
15	A tolerogenic peptide down‐regulates mature B cells in bone marrow of lupus‐afflicted mice by inhibition of interleukin‐7, leading to apoptosis Immunology ·Hava Ben‐David, Amir Sharabi, Reshmi Parameswaran, Heidy Zinger, Edna Mozes	2009	6
16	Targeting the Bone Marrow with Activin A-Overexpressing Embryonic Multipotent Stromal Cells Specifically Modifies B Lymphopoiesis Stem Cells and Development ·Reshmi Parameswaran, Vered Morad, Zdzisław Kółeczko, Liat Rousso-Noori, П. А. Трачук, Gan Yao-ku, Dov Zipori	2008	2
17	Activin βA in term placenta and its correlation with placental inflammation in parturients having epidural or systemic meperidine analgesia: a randomized study Journal of Clinical Anesthesia ·Shmuel Evron, Reshmi Parameswaran, Dov Zipori, Tiberiu Ezri, Oscar Sadan, Rumelia Koren	2007	20
18	Immunohistochemical localization of activin subunit in human placenta: Correlation with elevated temperature and placental infection in parturients laboring under epidural analgesia American Journal of Obstetrics and Gynecology ·Shmuel Evron, Rumelia Koren, Reshmi Parameswaran, Federal Institute of Hydrology, Tiberiu Ezri, Oscar Sadan, Dov Zipori	2004	3
19	The Mesenchymal Stroma Negatively Regulates B Cell Lymphopoiesis through the Expression of Activin A Annals of the New York Academy of Sciences ·Tsipi Shoham, Reshmi Parameswaran, Yaron Shav‐Tal, Mira Barda‐Saad, Dov Zipori	2003	19
20	The mesenchyme expresses T cell receptor mRNAs: relevance to cell growth control Oncogene ·Mira Barda‐Saad, Yaron Shav‐Tal, az Mabelis Menoya Díaz, Michal Cohen, Ayelet Zauberman, C Smith, Reshmi Parameswaran, Hadas Schori, Hagit Ashush, Avraham Ben‐Nun, Dov Zipori	2002	14

About Reshmi Parameswaran

Reshmi Parameswaran is a scholar working on Immunology, Genetics, Hematology, Oncology and Obstetrics and Gynecology, having authored 27 papers that have together received 525 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (7 papers), T-cell and B-cell Immunology (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Glycosylation and Glycoproteins Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), TGF-β signaling in diseases (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Immunology (243 citations), Oncology (178 citations), Hematology (57 citations), Genetics (40 citations) and Molecular Biology (219 citations). Reshmi Parameswaran has collaborated with scholars based in United States, Israel and Switzerland. Frequent co-authors include Parameswaran Ramakrishnan, Abhishek Asthana, Keman Zhang, John Groffen, Nora Heisterkamp, Rose Beck, Dov Zipori, Zhiqiang Xia, Kalpana Gupta and Marcos de Lima. Their work appears in journals such as Molecular Cancer Therapeutics, Blood, Nature Communications, Frontiers in Immunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact